PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening

BACKGROUND The 2012 United States Preventive Services Task Force recommendation against screening for prostate cancer has impacted rates of prostate‐specific antigen (PSA) screening and appears to be associated with declining prostate cancer incidence. Our objective was to characterize health care utilization that may explain these observed trends. METHODS MarketScan claims, which capture >30 million privately insured patients in the United...